Macugen 0.3mg Infusion
Marketer
Pfizer Ltd
Salt Composition
Pegaptanib (0.3mg)
Overview Macugen 0.3mg Infusion
Pegaptanib sodium 0.3mg injection treats wet age-related macular degeneration, a condition marked by abnormal blood vessel growth in the eye. This medication inhibits such growth, lessening swelling and leakage of fluid and blood, thereby reducing vision impairment. Administered directly into the eye by an ophthalmologist, self-injection is strictly prohibited. Typical side effects may include ocular pain, redness, blurred or diminished vision, and discharge. Persistent side effects or any concerning symptoms warrant immediate medical attention. Driving is discouraged post-injection due to potential drowsiness, dizziness, and impaired alertness.
Uses of Macugen 0.3mg Infusion
Age-related macular degeneration with fluid leakage
Major Benefits of Macugen 0.3mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Macugen 0.3mg Infusion:
- Foreign body sensation in eyes
- Increased intraocular pressure
- Eye pain
- Punctate keratitis
- Eye floaters
- Visual impairment
- Cataract
- Blurred vision
- Eye inflammation
- Stinging in the eyes
- High blood pressure
- Corneal edema
- Eye itching
- Conjunctival hemorrhage
- Burning sensation in eye
- Eye discharge
How to use Macugen 0.3mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Macugen 0.3mg Infusion works:
Intravitreal Macugen (0.3mg) is an anti-VEGF agent that inhibits vascular endothelial growth factor, thereby preventing the formation and permeability of aberrant ocular blood vessels, which can lead to visual impairment.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Macugen 0.3mg Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Macugen 0.3mg Infusion is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; yet, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The administration of Macugen 0.3mg via infusion is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administering Macugen 0.3mg Infusion could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Macugen 0.3mg Infusion use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 0.3mg Macugen infusions to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Macugen 0.3mg Infusion :
Should you forget a scheduled Macugen 0.3mg Infusion, contact your physician for guidance.
Facts to Know About Macugen 0.3mg Infusion
| Label | Value |
|---|---|
| Chemical Category | Short DNA or RNA sequences |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Behavior Class | VEGF inhibitor in age-related macular degeneration |
3,018 People bought this recently